Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a new site revision label: Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects an internal frontend update rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-08-30T12:08:51.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The sponsor institution name is updated to Second Affiliated Hospital, Zhejiang University, School of Medicine to reflect the proper organizational naming. The page revision tag is updated to v3.6.5, changing the documented version of the study record.
    Difference
    0.3%
    Check dated 2026-08-08T23:14:00.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4, indicating a minor metadata update to the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:56:28.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision tag on the study page was updated from v3.6.2 to v3.6.3. This indicates a small version update to the page metadata rather than a content change.
    Difference
    0.0%
    Check dated 2026-07-03T23:44:22.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-27T00:12:49.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    The study record was updated to standardize the Intervention/Treatment heading, add the investigator name Xuexin He and last-verified status, and include new help sections (How to Read a Study Record, Common Questions, How to Join a Study) with a revision tag Revision: v3.6.0. Removed the older items 'Intervention / Treatment', the full investigator attribution ('xuexin he, Second Affiliated Hospital, School of Medicine, Zhejiang University'), and the previous revision tag (Revision: v3.5.5).
    Difference
    1%
    Check dated 2026-06-12T23:32:44.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.